Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Uveitis-Induced Refractory Ocular Hypotony Managed With High-Dose Latanoprost Publisher



Ghassemi F1 ; Niyousha MR2 ; Hassanpoor N3, 4 ; Khojasteh H1
Authors
Show Affiliations
Authors Affiliations
  1. 1. Retina & Vitreous Service, Farabi Eye Hospital, Tehran University of Medical Sciences, Tehran, Iran
  2. 2. Retina & Vitreous Service, Nikookari Eye Hospital, Tabriz University of Medical Sciences, Tabriz, Iran
  3. 3. Ophthalmic Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran
  4. 4. Department of Ophthalmology, Tabriz University of Medical Sciences, Tabriz, Iran

Source: Journal of Ophthalmic and Vision Research Published:2020


Abstract

Purpose: To report a case of refractory ocular hypotony due to chronic Behcet’s disease with good response to high-dose topical latanoprost. Case Report: We present a 26-year-old man with a known history of Behcet’s disease who developed decreasing vision and severe ocular hypotony that was refractory to multiple treatment modalities including subtenon triamcinolone acetonide, ibopamine, pars plana vitrectomy, and silicone oil injection. We decided to try high-dose topical latanoprost for the management of ocular hypotony based on recent reports. After six months, intraocular pressure (IOP) increased by 5 mm Hg, became stable at 7 mm Hg, and remained unchanged at month 24. Conclusion: High-dose topical latanoprost could lead to significant increase in IOP in uveitis-induced refractory ocular hypotony. © 2020 JOURNAL OF OPHTHALMIC AND VISION RESEARCH